Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Discover practical ways to boost your income. Implement these strategies to increase your earnings and improve your financial situation.
19,559 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Authorities say 72 tigers died thai zoos in Chiang Mai from canine distemper, not bird flu, easing human health fears...
Kratos Defense stock keeps facing pressure after announcing a sizable stock sale. This guide breaks down dilution, it...
Google’s Gmail guru unveils a three-adopter framework for AI use, signaling a trust-first approach as Gmail rolls out...
UniFirst stock rocketing higher again today follows news of a blockbuster offer from Cintas. This article breaks down...
Oklo stock popped today after a regulatory milestone signaled progress for the company’s Aurora fast-fission technolo...
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Meta Platforms is pursuing a bold path toward a $9 trillion market cap by 2031. This article breaks down the feasibil...
The SpaceX IPO hype could pull even the most skeptical investors into ownership. This guide explains why even those a...
A surprising uptick in the memory sector has traders asking, 'Why is SanDisk stock today?' While SanDisk isn’t traded...
Private AI secondaries are heating up as Anthropic eyes a potential IPO. Market chatter warns the scene is a pressure...
When Cerebras surged 68% on its first trading day, investors sat up and took notice. This piece breaks down what that...